Literature DB >> 15944323

IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice.

Ali A Akhiani1, Anneli Stensson, Karin Schön, Nils Y Lycke.   

Abstract

We recently reported that Helicobacter pylori-specific Abs impair the development of gastritis and down-regulate resistance against H. pylori infection. In this study, we asked whether IgA Abs specifically can have an impact on H. pylori colonization and gastric inflammation. To obtain a sensitive model for the study of inflammation we crossed IgA- and IL-10-deficient mice. We found that IL-10(-/-)/IgA(-/-) mice were significantly less colonized than IL-10(-/-)/IgA(+/+) mice, which in turn were less colonized than wild-type (WT) mice. The IL-10(-/-)/IgA(-/-) mice exhibited a 1.2-log reduction in bacterial counts compared with that in IL-10(-/-)/IgA(+/+) mice, suggesting that IgA Abs rather promoted than prevented infection. The reduced colonization in IL-10(-/-)/IgA(-/-) mice was associated with the most severe gastritis observed, albeit all IL-10(-/-) mice demonstrated more severe gastric inflammation than wild-type mice. The gastritis score and the infiltration of CD4(+) T cells into the gastric mucosa were significantly higher in IL-10(-/-)/IgA(-/-) mice than in IL-10(-/-)/IgA(+/+) mice, arguing that IgA Abs counteracted inflammation. Moreover, following oral immunization, IL-10(-/-)/IgA(-/-) mice were significantly better protected against colonization than IL-10(-/-)/IgA(+/+) mice. However, the stronger protection was associated with more severe postimmunization gastritis and gastric infiltration of CD4(+) T cells. There was also a clear increase in complement receptor-expressing cells in IL-10(-/-)/IgA(-/-) mice, though C3b-fragment deposition in the gastric mucosa was comparable between the two. Finally, specific T cell responses to recall Ag demonstrated higher levels of IFN-gamma production in IL-10(-/-)/IgA(-/-) as compared with IL-10(-/-)/IgA(+/+) mice. Thus, it appears that IgA and IL-10 help H. pylori bacteria evade host resistance against infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944323     DOI: 10.4049/jimmunol.174.12.8144

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Helicobacter pylori Deregulates T and B Cell Signaling to Trigger Immune Evasion.

Authors:  Victor E Reyes; Alex G Peniche
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

2.  Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice.

Authors:  Mark T Whary; Nancy S Taylor; Yan Feng; Zhongming Ge; Suresh Muthupalani; James Versalovic; James G Fox
Journal:  Immunology       Date:  2011-03-23       Impact factor: 7.397

Review 3.  Helicobacter pylori and gastric cancer: factors that modulate disease risk.

Authors:  Lydia E Wroblewski; Richard M Peek; Keith T Wilson
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 4.  Role of innate immunity in Helicobacter pylori-induced gastric malignancy.

Authors:  Richard M Peek; Chris Fiske; Keith T Wilson
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

5.  Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients.

Authors:  Laura Neumann; Mattea Mueller; Verena Moos; Frank Heller; Thomas F Meyer; Christoph Loddenkemper; Christian Bojarski; Michael Fehlings; Thomas Doerner; Kristina Allers; Toni Aebischer; Ralf Ignatius; Thomas Schneider
Journal:  J Immunol       Date:  2016-07-25       Impact factor: 5.422

6.  Comparative role of immunoglobulin A in protective immunity against the Bordetellae.

Authors:  Daniel N Wolfe; Girish S Kirimanjeswara; Elizabeth M Goebel; Eric T Harvill
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

7.  Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity.

Authors:  Rebecca J Gorrell; Roy M Robins-Browne
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

8.  Contribution of secretory antibodies to intestinal mucosal immunity against Helicobacter pylori.

Authors:  Rebecca J Gorrell; Odilia L C Wijburg; John S Pedersen; Anna K Walduck; Terry Kwok; Richard A Strugnell; Roy M Robins-Browne
Journal:  Infect Immun       Date:  2013-08-05       Impact factor: 3.441

9.  Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations.

Authors:  Jennifer M Taylor; Melanie E Ziman; Julie Fong; Jay V Solnick; Michael Vajdy
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

10.  H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection.

Authors:  Anne Müller; Mathias Oertli; Isabelle C Arnold
Journal:  Cell Commun Signal       Date:  2011-11-01       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.